tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Satellos Bioscience Advances Phase 2 Trial for Duchenne Muscular Dystrophy Treatment
Company AnnouncementsSatellos Bioscience Advances Phase 2 Trial for Duchenne Muscular Dystrophy Treatment
6d ago
Promising Developments and Financial Stability Lead to Buy Rating for Satellos Bioscience
PremiumRatings
Promising Developments and Financial Stability Lead to Buy Rating for Satellos Bioscience
1M ago
Satellos Bioscience to Engage Investors at September Conferences
PremiumCompany Announcements
Satellos Bioscience to Engage Investors at September Conferences
1M ago
Satellos Bioscience Announces Positive Phase 1b Results and Upcoming Clinical Trials for DMD
PremiumCompany Announcements
Satellos Bioscience Announces Positive Phase 1b Results and Upcoming Clinical Trials for DMD
2M ago
Satellos Bioscience to Present at Canaccord Genuity’s Growth Conference
PremiumCompany Announcements
Satellos Bioscience to Present at Canaccord Genuity’s Growth Conference
2M ago
Satellos Bioscience to Present at Canaccord Genuity’s Growth Conference
PremiumCompany AnnouncementsSatellos Bioscience to Present at Canaccord Genuity’s Growth Conference
2M ago
Satellos Bioscience Appoints Dr. Wildon Farwell as Chief Medical Officer to Advance Neuromuscular Therapies
Premium
Company Announcements
Satellos Bioscience Appoints Dr. Wildon Farwell as Chief Medical Officer to Advance Neuromuscular Therapies
2M ago
Satellos Bioscience Reports Shareholder Meeting Outcomes and Strategic Approvals
Premium
Company Announcements
Satellos Bioscience Reports Shareholder Meeting Outcomes and Strategic Approvals
3M ago
Satellos Bioscience to Engage with Duchenne Community at PPMD Conference
PremiumCompany Announcements
Satellos Bioscience to Engage with Duchenne Community at PPMD Conference
3M ago
Satellos Bioscience Reports Promising Phase 1b Trial Results for DMD Treatment
PremiumCompany Announcements
Satellos Bioscience Reports Promising Phase 1b Trial Results for DMD Treatment
4M ago
Satellos Bioscience Advances DMD Drug Trials with Positive Financial Outlook
PremiumCompany Announcements
Satellos Bioscience Advances DMD Drug Trials with Positive Financial Outlook
5M ago
Satellos Bioscience to Present at CureDuchenne FUTURES Conference
PremiumCompany Announcements
Satellos Bioscience to Present at CureDuchenne FUTURES Conference
5M ago
Satellos Bioscience to Present at Healthcare Investor Conference
PremiumCompany AnnouncementsSatellos Bioscience to Present at Healthcare Investor Conference
5M ago
Satellos Bioscience to Engage with Investors at April Conferences
Premium
Company Announcements
Satellos Bioscience to Engage with Investors at April Conferences
6M ago
Satellos Bioscience: Buy Rating Backed by Promising Clinical Progress and Robust Financial Position
Premium
Ratings
Satellos Bioscience: Buy Rating Backed by Promising Clinical Progress and Robust Financial Position
6M ago
Satellos Bioscience Advances DMD Therapy with Promising Trial Results
PremiumCompany Announcements
Satellos Bioscience Advances DMD Therapy with Promising Trial Results
6M ago
MSCLF Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
MSCLF Upcoming Earnings Report: What to Expect?
6M ago
Satellos Bioscience Reports Positive Initial Data from Phase 1 Trial of SAT-3247
PremiumCompany Announcements
Satellos Bioscience Reports Positive Initial Data from Phase 1 Trial of SAT-3247
6M ago
Satellos Bioscience to Present Phase 1 Data for SAT-3247 at MDA Conference
PremiumCompany Announcements
Satellos Bioscience to Present Phase 1 Data for SAT-3247 at MDA Conference
7M ago
Satellos Completes Phase 1 Enrollment for DMD Drug Trial
PremiumCompany AnnouncementsSatellos Completes Phase 1 Enrollment for DMD Drug Trial
8M ago
Satellos Bioscience to Showcase at Oppenheimer Healthcare Conference
Premium
Company Announcements
Satellos Bioscience to Showcase at Oppenheimer Healthcare Conference
8M ago
Satellos Bioscience price target raised to C$1.25 from C$1 at Canaccord
Premium
The Fly
Satellos Bioscience price target raised to C$1.25 from C$1 at Canaccord
9M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >